The sGC-cGMP Signaling Pathway as a Potential Therapeutic Target in Doxorubicin-Induced Heart Failure: A Narrative Review.
Am J Cardiovasc Drugs
; 22(2): 117-125, 2022 Mar.
Article
in En
| MEDLINE
| ID: mdl-34151411
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cyclic GMP
/
Heart Failure
Limits:
Humans
Language:
En
Journal:
Am J Cardiovasc Drugs
Journal subject:
ANGIOLOGIA
/
CARDIOLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2022
Document type:
Article
Country of publication:
New Zealand